Literature DB >> 12237593

Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999.

Shelah Leader1, Kimmie Kohlhase.   

Abstract

BACKGROUND: The recent number and rate of infant hospitalizations with a respiratory syncytial virus (RSV)-coded diagnosis have not been published.
METHODS: Retrospective data analysis. National Hospital Discharge Survey data for 1997 to 1999 were analyzed for discharges of infants < 1 year old with an RSV-coded diagnosis (ICD-9-CM 466.11, 480.1, 079.6). Hospitalization rates were estimated with annual midyear Census data.
RESULTS: RSV bronchiolitis was the leading primary diagnosis annually for all infants hospitalized for any reason. Between 1997 and 1999, 297 684 RSV-coded discharges of infants with an RSV-coded diagnosis occurred. The associated hospitalization rate was 25.2 per 1000 infants. RSV-coded discharges peaked in February.
CONCLUSION: RSV bronchiolitis was the leading cause of hospital admissions of infants younger than age 1 year for any reason between 1997 and 1999.

Entities:  

Mesh:

Year:  2002        PMID: 12237593     DOI: 10.1097/00006454-200207000-00005

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  92 in total

Review 1.  Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis.

Authors:  Karen A Robinson; Olaide A Odelola; Ian J Saldanha
Journal:  Cochrane Database Syst Rev       Date:  2016-07-20

2.  Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis.

Authors:  Carla G García; Rafia Bhore; Alejandra Soriano-Fallas; Margaret Trost; Rebecca Chason; Octavio Ramilo; Asuncion Mejias
Journal:  Pediatrics       Date:  2010-11-22       Impact factor: 7.124

3.  Acute respiratory admissions in Thessaloniki, Greece: 14-year follow-up.

Authors:  E Hatziagorou; F Kirvassilis; S Saraphidou; M Katsara; R Valeri; M Emporiadou; C Magnisali; J Tsanakas
Journal:  Hippokratia       Date:  2009-10       Impact factor: 0.471

Review 4.  Perinatal and early childhood environmental factors influencing allergic asthma immunopathogenesis.

Authors:  Jonathan M Gaffin; Watcharoot Kanchongkittiphon; Wanda Phipatanakul
Journal:  Int Immunopharmacol       Date:  2014-06-19       Impact factor: 4.932

5.  Respiratory syncytial virus load, viral dynamics, and disease severity in previously healthy naturally infected children.

Authors:  Chadi M El Saleeby; Andy J Bush; Lisa M Harrison; Jody A Aitken; John P Devincenzo
Journal:  J Infect Dis       Date:  2011-10-01       Impact factor: 5.226

6.  Determinants of asthma after severe respiratory syncytial virus bronchiolitis.

Authors:  Leonard B Bacharier; Rebecca Cohen; Toni Schweiger; Huiquing Yin-Declue; Chandrika Christie; Jie Zheng; Kenneth B Schechtman; Robert C Strunk; Mario Castro
Journal:  J Allergy Clin Immunol       Date:  2012-03-22       Impact factor: 10.793

Review 7.  Host and Viral Determinants of Respiratory Syncytial Virus-induced Airway Mucus.

Authors:  Matthew T Stier; R Stokes Peebles
Journal:  Ann Am Thorac Soc       Date:  2018-11

Review 8.  Human genetic factors and respiratory syncytial virus disease severity.

Authors:  Isao Miyairi; John P DeVincenzo
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

9.  Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV.

Authors:  Bart Jones; Xiaoyan Zhan; Vasiliy Mishin; Karen S Slobod; Sherri Surman; Charles J Russell; Allen Portner; Julia L Hurwitz
Journal:  Vaccine       Date:  2009-02-04       Impact factor: 3.641

10.  Respiratory viruses in bronchiolitis and their link to recurrent wheezing and asthma.

Authors:  Jonathan M Mansbach; Carlos A Camargo
Journal:  Clin Lab Med       Date:  2009-12       Impact factor: 1.935

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.